Showing results (61-70 of 102) with videos related to

Sort By:
Pageof 11
Leukemia & Lymphoma|November 5, 2021
Bone marrow ribonucleotide reductase mRNA levels and methylation status as prognostic factors in patients with myelodysplastic syndrome treated with 5-AzacytidineChristina-Nefeli Kontandreopoulou, Panagiotis T Diamantopoulos, Andreas Giannopoulos, et al.
Medicina (Kaunas, Lithuania)|August 27, 2021
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in GreeceIoannis Kakkas, Gerasimina Tsinti, Fani Kalala, et al.
Foods (Basel, Switzerland)|April 12, 2022
Physicochemical Characterization and Biological Properties of Pine Honey Produced across GreeceEleni Tsavea, Fotini-Paraskevi Vardaka, Elisavet Savvidaki, et al.
Biomed Research International|August 28, 2014
Serum soluble TACI, a BLyS receptor, is a powerful prognostic marker of outcome in chronic lymphocytic leukemiaMarie-Christine Kyrtsonis, Katerina Sarris, Efstathios Koulieris, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
CD138 expression helps distinguishing Waldenström's macroglobulinemia (WM) from splenic marginal zone lymphoma (SMZL)Marie-Christine Kyrtsonis, Georgia Levidou, Penelope Korkolopoulou, et al.
Annals of Hematology|March 17, 2019
Bone marrow PARP1 mRNA levels predict response to treatment with 5-azacytidine in patients with myelodysplastic syndromePanagiotis T Diamantopoulos, Christina-Nefeli Kontandreopoulou, Argiris Symeonidis, et al.
Cancers|September 10, 2021
Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective StudyEvangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, et al.
British Journal of Haematology|April 6, 2007
Prognostic value of serum free light chain ratio at diagnosis in multiple myelomaMarie-Christine Kyrtsonis, Theodoros P Vassilakopoulos, Nicoletta Kafasi, et al.
Advances in Hematology|November 30, 2013
Prognostic significance of serum free light chains in chronic lymphocytic leukemiaKaterina Sarris, Dimitrios Maltezas, Efstathios Koulieris, et al.
Hematological Oncology|September 11, 2012
Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agentsDimitrios Maltezas, Meletios A Dimopoulos, Irene Katodritou, et al.
Pageof 11